Orifarm Unveils 2031 Strategy to Accelerate Growth Across Europe, With Significant Expansion in Generics

Contributed by: Business Wire

Logo

Images

Mads Fink Eriksen, CEO Orifarm

Business Wire embedded0

Tags

Medical Supplies

Health

Other Health

General Health

Pharmaceutical

Biotechnology

Fit to Scale

More Like This

Alfasigma Reports Solid Performance in 2025 Supported by Double-Digit Revenue Growth in key strategic brands in Immunology (+17%1), Gastroenterology (+15%), Vascular (+10%), and Consumer Healthcare expansion portfolio in international markets

Farmasiet, Norway’s largest online pharmacy, signs Agillic for advanced customer engagement

PR Newswire associated0

Zentiva Joins the Call to Action to Finalize Pharmaceutical Reform and Secure Sustainable Healthcare for People in Europe

Navamedic Q2 and H1 2024: Stable growth continues and is supported by a new licensing and supply agreement

Polpharma Group Calls for Urgent Action to Protect early equitable access to medicines for European patients

PR Newswire associated0

Norgine announces £23 million new investment as part of more than £50 million committed to expanding medicines manufacturing in Wales

FAMAR Group expands its manufacturing footprint in Northern Europe with the acquisition of a sterile production site in Homburg

FAMAR Group Expands Its Manufacturing Footprint In Northern Europe

Polpharma Group Supports Urgent EU Action to Safeguard Access to Medicines and Strengthen European Pharmaceutical Sovereignty